Home › Bleeding › North Carolina › Durham
Bleeding clinical trials in Durham, NC
6 studies for Bleeding are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
RecruitingPhase 3
- Science 37, Durham
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Duke University Hospital, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Duke University Hospital, Durham
Onyx™ Liquid Embolic IDE Clinical Study
Recruiting
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Duke University Health System, Durham
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RecruitingPhase 3
- Duke University, Durham
About Bleeding
Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.
More about Bleeding on MedlinePlus
Bleeding trials in other cities
- Boston, MA10 studies
- New York City, NY10 studies
- Houston, TX8 studies
- Cleveland, OH6 studies
- Los Angeles, CA6 studies
- Atlanta, GA6 studies
- Indianapolis, IN6 studies
- Chicago, IL6 studies
- St. Louis, MO5 studies
- Philadelphia, PA5 studies
- Seattle, WA5 studies
- San Diego, CA5 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)61 studies
- Non-Small Cell Lung Cancer42 studies
- Multiple Myeloma36 studies
- Acute Myeloid Leukemia34 studies
- Lung Cancer33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Colorectal Cancer30 studies
- Ovarian Cancer28 studies
- Chronic Lymphocytic Leukemia28 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.